EVEROLIMUS vs KOSELUGO

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. EVEROLIMUS and KOSELUGO are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	EVEROLIMUS	KOSELUGO
Rating	72/100	70/100
Pharmacy pays	~$219.28 /30	—
Type	RX	RX
Active ingredient	EVEROLIMUS	SELUMETINIB SULFATE
Manufacturer	Biocon Pharma	Astrazeneca
Dosage forms	Tablet	Capsule, Powder
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	Boxed warning	None
Half-life	about 30 hours (mean terminal elimination half-life)	—
Treats	—	Neurofibromatosis 1

everolimus koselugo

Rating

72/100

70/100

Pharmacy pays

~$219.28 /30

—

Type

Active ingredient

EVEROLIMUS

SELUMETINIB SULFATE

Manufacturer

Biocon Pharma

Astrazeneca

Dosage forms

Tablet

Capsule, Powder

Drug class

Kinase Inhibitor

Boxed warning

None

Half-life

about 30 hours (mean terminal elimination half-life)

—

Treats

—

Neurofibromatosis 1

Frequently asked questions

Which is better-rated, Everolimus or Koselugo?

By our independent rating, Everolimus scores higher — 3.6 vs 3.5 out of 5 for Koselugo. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Everolimus and Koselugo?

Everolimus contains Everolimus, while Koselugo contains Selumetinib Sulfate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.